In the Spotlight

13 July 2016

Pfizer and NovaMedica announce a strategic partnership in Russia

Pfizer, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by RMI and Domain Associates, have announced the start of a long-term strategic partnership to locally manufacture and bring to the Russian market a number of important medicines. The first step will be the construction of a modern pharmaceutical manufacturing plant located in the Vorsino industrial park, Kaluga Region. 

15 December 2015

NovaMedica is starting construction of R&D Center for drug development using nanotechnologies

NovaMedica, a Russian pharmaceutical company, is starting construction of R&D Center for innovative drug development and pilot production in Moscow. This Center will include laboratories and production areas equipped with state-of-the-art process equipment that has never been used in the Russian pharmaceutical industry before. The total investments are estimated approximately $15 million.

18 June 2015

NovaMedica is planning to create around 15 innovative nanotech-involved pharmaceutical products

A Russian pharmaceutical company NovaMedica is planning to grow its R&D activities targeted at building a portfolio of proprietary nanotech-involving pharmaceutical products. This is what has been announced today by Vladimir Gurdus, General Manager at RMI Partners, managing company of NovaMedica, at the Annual Saint Petersburg International Economic Forum during his panel discussion titled “Nanotechnologies – meeting the expectations?”

18 June 2014

Vladimir Gurdus to speak about latest developments of RMI and NovaMedica projects at 20th Pharmaceutical Forum in St. Petersburg

“We have worked our way up from the concept of the RMI portfolio building to first sales of NovaMedica pharmaceutical company within two years’ time. This pace of development is considered fast in the pharmaceutical industry”, - Vladimir Gurdus, CEO, RMI Partners, Management Company of RMI and NovaMedica said during his speech at 20^th Russian Pharmaceutical Forum in St. Petersburg.

04 June 2014

Focusing on the journey, not the destination, however, taking the whole winner’s stand, is the Russia’s hallmark - Facbrice Egros

Pharmatsevtichesky Vestnik – Pharmaceutical Bulletin

NovaMedica’s leader Fabrice Egros told Oksana Baranova, Pharmatsevtichesky Vestnik – Pharmaceutical Bulletin correspondent, about how the expats visualize and estimate prospects of the Russian pharmaceutical market.

23 May 2014

SPIEF2014. Leonid Melamed: Apparently, the one, who shall benefit from the development of public-private partnerships, is the patient

In general terms, engagement of private companies in the healthcare system on a competitive basis shall result in the price optimization and improvement of the quality of medical services provided and pharmaceuticals delivered to patients, Leonid Melamed, Chairman of the Board, Team Drive; Member of the Board of Directors, RusnanoMedInvest and NovaMedica said on Friday at St. Petersburg SPIEF2014.

17 January 2014

RMI’s Gopka Seeks Revolutionary Science, Industry Relationships

Jennifer Boggs, BIO World Today

Making the move from investment banking to the world of venture capital at first sounded as though it would yield more free time and a more relaxing occupation; instead, as a managing partner at RMI Partners, Anton Gopka has found himself busier than ever, perhaps never more so than during this year’s J.P. Morgan Healthcare Conference.

17 September 2013

Regado Biosciences, Inc. enrolls first patient in phase 3 trial of REG1

Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.  

25 July 2013

NovaMedica, Kaluga Region and City of Kaluga Sign Agreement on Construction of Pharmaceutical Plant

The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.

03 June 2013

S.Fyodorov Eye Microsurgery Complex and NovaMedica have signed a cooperation agreement on localizing innovative ophthalmic treatment technologies in Russia

S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.